Developing resources and workforce for research on high-priority pathogens.
Official title: Resources and Workforce Development for Research on NIH/NIAID High Priority Pathogens at the University of Missouri Regional Biocontainment Laboratory
Funded at University of Missouri-Columbia · NIH-10910190 · Data updated 2026-11-12
This study is all about making the University of Missouri's lab better at studying important germs, like those that cause COVID-19, so that researchers can find new treatments and keep everyone safer during outbreaks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $2,375,210 |
| NIH project number | 5UC7AI180306-02 |
| Project ID | NIH-10910190 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals affected by or at risk for infectious diseases, particularly those related to COVID-19.
✕Less likely to help
Patients with non-infectious diseases or those not impacted by high-priority pathogens may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing the capabilities of the University of Missouri's Regional Biocontainment Laboratory to study high-priority pathogens, including those related to COVID-19. It aims to improve research resources and workforce development, ensuring that researchers have access to state-of-the-art equipment and professional services. The laboratory collaborates with national networks to share knowledge and best practices, ultimately strengthening the nation's preparedness for infectious disease outbreaks. Patients may benefit indirectly through improved research outcomes and advancements in treatment options.
Why it matters
Potential benefit: If successful, this research could lead to better preparedness and response strategies for infectious diseases, potentially improving patient outcomes during outbreaks.
How similar studies have gone: Other research initiatives focused on high-priority pathogens have shown success in enhancing preparedness and response strategies, indicating that this approach is both relevant and necessary.
Where this research is happening
-
University of Missouri-Columbia
Columbia, United States Active
Researchers
- Principal investigator: Griffiths, Anthony — University of Missouri-Columbia
- Study coordinator: Griffiths, Anthony
Related research
Other NIH-funded projects on the same topics.
-
Boosting immune response to fight cancer
This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.
-
Interface between immune cells and scarring in the eye
This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.
-
Understanding cell-cleanup problems in C9ORF72-related ALS/FTD
Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.
-
Molecular clues to endometriosis-related infertility
This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.
-
A universal Shigella vaccine using SAVE to protect people of all ages
A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.
-
Biomarkers that predict osteoarthritis risk in people at higher risk
A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.